The store will not work correctly when cookies are disabled.
7-(3-propylphenyl)-1-(pyrrolidin-1-yl)heptan-1-one
ID: ALA4462559
PubChem CID: 155529210
Max Phase: Preclinical
Molecular Formula: C20H31NO
Molecular Weight: 301.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCc1cccc(CCCCCCC(=O)N2CCCC2)c1
Standard InChI: InChI=1S/C20H31NO/c1-2-10-18-12-9-13-19(17-18)11-5-3-4-6-14-20(22)21-15-7-8-16-21/h9,12-13,17H,2-8,10-11,14-16H2,1H3
Standard InChI Key: PGDAQOCXEFRJRU-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
24.0040 -13.5621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7117 -13.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4194 -13.5621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2963 -13.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5885 -13.5621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8808 -13.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1731 -13.5621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4654 -13.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7577 -13.5621 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4654 -12.3363 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0077 -13.2282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4609 -13.8355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8696 -14.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6688 -14.3732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4168 -14.3803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1237 -14.7888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8324 -14.3802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8298 -13.5588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1223 -13.1540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1233 -15.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8308 -16.0150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8304 -16.8322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 9 1 0
3 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 3 1 0
16 20 1 0
20 21 1 0
21 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 301.47 | Molecular Weight (Monoisotopic): 301.2406 | AlogP: 4.75 | #Rotatable Bonds: 9 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 1 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.28 | CX LogD: 5.28 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.60 | Np Likeness Score: -0.47 |
References
1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y.. (2019) Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors., 10 (2): [PMID:30931090] [10.1039/C8MD00432C] |